Jury selection begins for trial of home guru Martha Stewart
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Martha Stewart is used to being in the spotlight - on television, on the covers of her magazines, in promotions for her linen - evangelising on the art of maintaining the perfect home, from the pine-scented bathroom to the copper-potted kitchen. But now her stage is to be the dock of a courtroom.
Jury selection begins today for a trial in Manhattan that may see the once-serene world of Ms Stewart come crumbling down. When testimony starts later this month, all of America will be awaiting the fate of the nation's most loved home-making guru.
The allegations against Ms Stewartdate from 27 December 2001, when she sold all of a small stake she held in a biotech company called ImClone. The transaction was worth $228,000 (£126,000), small change for her. But very soon federal investigators were chasing her. The day before, Sam Waksal, the founder and head of ImClone - and a long-time friend of Ms Stewart - had also offloaded shares in the company. He did so because he had got an early warning that the government was set to refuse approval for a cancer drug the company had been developing. Waksal, who was jailed last year for insider trading, knew the finding would crush ImClone's shares.
Prosecutors are preparing to argue that Ms Stewart acted after being tipped off by Waksal or by Peter Baconovic, the broker they both used. Although she has not been charged with insider trading, prosecutors will accuse her of trying to obstruct justice, of lying about the circumstances of her shares sale, tampering with phone records and doctoring other records. If found guilty, she could be jailed for 10 years.
The fortunes of her company, Martha Stewart Living Omnimedia, have been badly dented already. She has proclaimed her innocence, rather than going for a plea deal and the likelihood of a milder sentence. She argues that she had a prior arrangement with her broker that he would sell her ImClone shares if they fell below $60 each, as, indeed, they had.But the greatest unknown for Ms Stewart and her lawyers will be the kind of jury that considers the case. She admitted there is something about her that drives millions to loathe her. If the jurors are among those Stewart-haters, she may be doomed.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments